Supernus Pharmaceuticals ... (SUPN)
31.98
-0.31 (-0.96%)
At close: Mar 31, 2025, 10:20 AM
13F Institute Ownership
Total Institutes of 293 in Supernus Pharmaceuticals expanded their positions with an increase of 21 investors compared to the previous quarter. A reduction of 312.95K shares, as total invested capital grew by $285.9M with ownership percentage dropping from 108.27% to 107.70%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.269
0.27
Call Flow 22,300
79%
Put Flow 6,000
21%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 18.13% | 10M | -0.69% | 361.53M | < 0.01% |
| Vanguard Group Inc | 11.15% | 6.15M | +0.37% | 222.41M | < 0.01% |
| Armistice Capital, LLC | 8.77% | 4.84M | -5.1% | 174.87M | 2.39% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.